company background image
A092730 logo

NeoPharm KOSDAQ:A092730 Voorraadrapport

Laatste prijs

₩13.20k

Marktkapitalisatie

₩206.5b

7D

-1.5%

1Y

6.7%

Bijgewerkt

04 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

NeoPharm CO., LTD.

KOSDAQ:A092730 Voorraadrapport

Marktkapitalisatie: ₩206.5b

NeoPharm CO., LTD. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor NeoPharm
Historische aandelenkoersen
Huidige aandelenkoers₩13,200.00
52 Week Hoogtepunt₩17,150.00
52 Week Laag₩10,075.00
Bèta0.77
11 maand verandering4.35%
3 maanden verandering17.33%
1 Jaar Verandering6.67%
33 jaar verandering1.54%
5 jaar verandering-45.79%
Verandering sinds IPO217.78%

Recent nieuws en updates

Recent updates

NeoPharm CO., LTD.'s (KOSDAQ:092730) Earnings Are Not Doing Enough For Some Investors

Sep 13
NeoPharm CO., LTD.'s (KOSDAQ:092730) Earnings Are Not Doing Enough For Some Investors

NeoPharm (KOSDAQ:092730) Will Want To Turn Around Its Return Trends

Aug 07
NeoPharm (KOSDAQ:092730) Will Want To Turn Around Its Return Trends

NeoPharm CO., LTD. (KOSDAQ:092730) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Jun 13
NeoPharm CO., LTD. (KOSDAQ:092730) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Benign Growth For NeoPharm CO., LTD. (KOSDAQ:092730) Underpins Its Share Price

Apr 24
Benign Growth For NeoPharm CO., LTD. (KOSDAQ:092730) Underpins Its Share Price

NeoPharm's (KOSDAQ:092730) Earnings Are Weaker Than They Seem

Mar 25
NeoPharm's (KOSDAQ:092730) Earnings Are Weaker Than They Seem

Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

Mar 28
Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

Mar 15
What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

How Much Did NeoPharm's(KOSDAQ:092730) Shareholders Earn From Share Price Movements Over The Last Three Years?

Mar 02
How Much Did NeoPharm's(KOSDAQ:092730) Shareholders Earn From Share Price Movements Over The Last Three Years?

We're Watching These Trends At NeoPharm (KOSDAQ:092730)

Feb 18
We're Watching These Trends At NeoPharm (KOSDAQ:092730)

We're Not So Sure You Should Rely on NeoPharm's (KOSDAQ:092730) Statutory Earnings

Feb 08
We're Not So Sure You Should Rely on NeoPharm's (KOSDAQ:092730) Statutory Earnings

NeoPharm CO., LTD. (KOSDAQ:092730) Has Got What It Takes To Be An Attractive Dividend Stock

Jan 26
NeoPharm CO., LTD. (KOSDAQ:092730) Has Got What It Takes To Be An Attractive Dividend Stock

An Intrinsic Calculation For NeoPharm CO., LTD. (KOSDAQ:092730) Suggests It's 31% Undervalued

Jan 15
An Intrinsic Calculation For NeoPharm CO., LTD. (KOSDAQ:092730) Suggests It's 31% Undervalued

Will Weakness in NeoPharm CO., LTD.'s (KOSDAQ:092730) Stock Prove Temporary Given Strong Fundamentals?

Jan 04
Will Weakness in NeoPharm CO., LTD.'s (KOSDAQ:092730) Stock Prove Temporary Given Strong Fundamentals?

NeoPharm CO., LTD. (KOSDAQ:092730) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Dec 24
NeoPharm CO., LTD. (KOSDAQ:092730) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

Dec 15
What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

Dec 04
Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

Would Shareholders Who Purchased NeoPharm's (KOSDAQ:092730) Stock Year Be Happy With The Share price Today?

Nov 23
Would Shareholders Who Purchased NeoPharm's (KOSDAQ:092730) Stock Year Be Happy With The Share price Today?

Rendement voor aandeelhouders

A092730KR Personal ProductsKR Markt
7D-1.5%0.3%-1.2%
1Y6.7%-2.6%4.8%

Rendement versus industrie: A092730 exceeded the KR Personal Products industry which returned -2.6% over the past year.

Rendement versus markt: A092730 exceeded the KR Market which returned 4.8% over the past year.

Prijsvolatiliteit

Is A092730's price volatile compared to industry and market?
A092730 volatility
A092730 Average Weekly Movement6.1%
Personal Products Industry Average Movement7.6%
Market Average Movement6.7%
10% most volatile stocks in KR Market12.2%
10% least volatile stocks in KR Market3.5%

Stabiele aandelenkoers: A092730 has not had significant price volatility in the past 3 months compared to the KR market.

Volatiliteit in de loop van de tijd: A092730's weekly volatility (6%) has been stable over the past year.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
2000172Byeong-Deog Parkwww.neopharm.co.kr

NeoPharm CO., LTD. houdt zich bezig met de productie en verkoop van huidverzorgingsproducten in Zuid-Korea. Het bedrijf levert Atopalm, een niet-steroïde product voor de gevoelige en droge huid; dermocosmetische huidproducten onder de merknaam Real Barrier; gevoelige, droge, vette of probleemhuidverzorgingsproducten onder de merknaam ZEROID; vochtinbrengende crèmes voor het lichaam onder de merknaam Derma-B; sportverzorgingsproducten onder de merknaam MISSION ATHELETCARE; en dermArtlogy, een cosmeticamerk voor 1:1 advies.

NeoPharm CO., LTD. Samenvatting

Hoe verhouden de winst en inkomsten van NeoPharm zich tot de beurswaarde?
A092730 fundamentele statistieken
Marktkapitalisatie₩206.46b
Inkomsten(TTM)₩22.93b
Inkomsten(TTM)₩107.86b

9.0x

Koers/Winstverhouding

1.9x

P/S-verhouding

Is A092730 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
A092730 resultatenrekening (TTM)
Inkomsten₩107.86b
Kosten van inkomsten₩41.22b
Brutowinst₩66.64b
Overige uitgaven₩43.71b
Inkomsten₩22.93b

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)1.47k
Brutomarge61.79%
Nettowinstmarge21.26%
Schuld/Eigen Vermogen Verhouding0%

Hoe presteerde A092730 op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

2.8%

Huidig dividendrendement

26%

Uitbetalingsratio